PIK3CD and acute myeloid leukemia: In addition, Pillinger et al. [30] revealed that PI3K inhibition using three PI3K inhibitors, LY294002, IPI-145, and CAL-101, significantly reduced the survival of AML cells in vitro or in vivo.